等待開盤 09-23 09:30:00 美东时间
+2.350
+4.02%
今日重点评级关注:Ascendiant Capital:维持Outlook Therapeutics"买入"评级,目标价从10美元升至10.5美元;摩根士丹利:维持Aurora Innovation"超配"评级,目标价从14美元升至18美元
09-14 16:05
Wells Fargo analyst Sam Reid maintains Builders FirstSource (NYSE:BLDR) with a Equal-Weight and lowers the price target from $65 to $63.
09-11 22:30
On CNBC’s “Mad Money Lightning Round,” Jim Cramer said Akamai Technologies, Inc. (NASDAQ:AKAM) is “terrific.” Lending support to his choice, Akami Technologies, on Aug. 6, reported better-than-expected second-quarter financial results. Akamai reported quarterly earnings of $1.59 per share, which bea...
09-10 19:34
Builders FirstSource (NYSE:BLDR) has outperformed the market over the past 10 years by 5.0% on an annualized basis producing an average annual return of 18.39%. Currently, Builders FirstSource has a market capitalization of $7.53 billion. Buying $100 In BLDR: If an investor had bought $100 of BLDR s...
08-21 00:01
Builders FirstSource (NYSE:BLDR) has outperformed the market over the past 10 years by 6.45% on an annualized basis producing an average annual return of 19.91%. Currently, Builders FirstSource has a market capitalization of $8.02 billion. Buying $100 In BLDR: If an investor had bought $100 of BLDR ...
08-07 22:45
今日重点评级关注:TD Cowen:维持加拿大鹅"买入"评级,目标价从13美元升至18美元;瑞银:维持吉登运动服"买入"评级,目标价从110美元升至111美元
08-03 11:38
Barclays analyst Matthew Bouley maintains Builders FirstSource (NYSE:BLDR) with a Overweight and lowers the price target from $93 to $81.
07-31 19:01
今日重点评级关注:HC Wainwright & Co.:维持Q32 Bio"买入"评级,目标价从13美元升至36美元;Chardan Capital:维持ProMIS Neurosciences"买入"评级,目标价从20美元升至33美元
07-29 11:37
今日重点评级关注:伯恩斯坦:维持ServiceNow"跑赢大市"评级,目标价从236美元升至248美元;HC Wainwright & Co.:维持NovoCure"买入"评级,目标价从46美元升至52美元
07-24 11:37
Stifel analyst W. Andrew Carter maintains Builders FirstSource (NYSE:BLDR) with a Hold and lowers the price target from $76 to $70.
07-23 21:17